Le Lézard
Classified in: Mining industry, Science and technology
Subjects: TDS, BFA

Omron to Showcase Cutting-Edge Inspection and Factory Automation Solutions at IPC APEX EXPO 2024


Explore Omron's advanced technology in 3D inspection machines at IPC APEX EXPO 2024 offering speed, reliability, and accuracy for various industries.

HOFFMAN ESTATES, Ill., March 14, 2024 /PRNewswire/ -- OMRON Automation Americas, a global leader in industrial automation solutions will be exhibiting at IPC APEX 2024, taking place at the Anaheim Convention Center from April 9th to April 11th. Attendees are invited to visit Omron's booth #2647 to hear how AI powers Omron's latest technology, in addition to learning more about our newest X-Ray inspection machine, the VT-X850. This new 3D CT X-Ray inspection system is designed specifically for electric vehicle (EV) surface mount technology (SMT) manufacturing lines.

Visitors can expect to see a full line of 3D inspection solutions, including the VT-X750 and VT-S1080. Built with Omron's robust Sysmac platform, each machine offers unparalleled speed, reliability, and accuracy, making them ideal for a variety of mission-critical applications found in automotive, medical, aerospace, and semiconductor industries. Visit the Sysmac display and Sysmac Modular machine at the booth to learn more about the next generation of industrial controls for electronics manufacturing.

"We are excited to showcase our cutting-edge inspection solutions at IPC APEX EXPO 2024," said Brad Ward, Technical Manager - Traceability & Inspection Solutions at Omron. "Our goal is to provide our customers with the highest quality, most reliable, and technologically advanced inspection solutions. We invite all attendees to visit our booth and discover how Omron can help them achieve their inspection goals."

To learn more about IPC APEX EXPO 2024, please visit here.

About Omron Automation

Industrial automation partner that creates, sells, and services fully integrated automation solutions that include sensing, control, safety, vision, motion, robotics, and more. Established in 1933, Omron's about 30,000 employees help businesses solve problems with creativity in more than 110 countries. Learn more at Omron Industrial Automation | Omron

Contact: Amy Wang, [email protected]

SOURCE Omron Automation Americas


These press releases may also interest you

at 02:34
Elbit Systems Awarded $37 Million Contract to Supply Iron Fist APS for Upgrading U.S. Army's Bradley IFVs
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based Iozera announces MOU with Government of Morocco for Launch of Eco-Friendly AI Data Center in Morocco
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
Flash News: OK Wallet Now Integrated with JUICE, a Permissionless DeFi Protocol Built on the Blast Ecosystem's Layer 2 Infrastructure
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Quick understanding of JA Solar's 2023 annual report
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...

More news about Science and technology...


News published on and distributed by: